What is Tyra Biosciences Inc (TYRA) stock price today?

Tyra Biosciences Inc (TYRA) currently trades at $34.75 per share. The stock has a market capitalization of $2.01B and a P/E ratio of —x.

Is TYRA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Tyra Biosciences Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 9.13.

Is Tyra Biosciences Inc financially healthy?

Tyra Biosciences Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 9.13 places it in the safe zone.

TYRA

Tyra Biosciences Inc

NASDAQ: TYRA · HEALTHCARE · BIOTECHNOLOGY

$34.75

+2.86% today

Updated 2026-04-30

Market cap

$2.01B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.01

Dividend yield

—

52W range

$9 – $41

Volume

1.2M

Market cap

$2.01B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.01

Dividend yield

—

52W range

$9 – $41

Volume

1.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

9.1

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$51.24

+47.45%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 9.13 — safe zone

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-23.68M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-51.72M	$-69.13M	$-86.48M	$-119.95M	$-33.83M
EPS	—	—	—	—	$-2.01
Free cash flow	$-50.84M	$-50.91M	$-70.44M	$-95.28M	$-23.68M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TYRA	$2.01B	25	4.3	3.0	5.0	7.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Tyra Biosciences Inc trades at $34.75. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 9.13, it sits in the safe zone.

Frequently asked questions

What is Tyra Biosciences Inc's stock price?

Tyra Biosciences Inc (TYRA) trades at $34.75.

Is Tyra Biosciences Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Tyra Biosciences Inc (TYRA)?

The analyst target price is $51.24, representing +47.5% upside from the current price of $34.75.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

9.13 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-39.80%

Beta0.96

50D MA$35.64

200D MA$22.59

Shares out0.06B

Float0.03B

Short ratio—

Avg volume1.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TYRA vs LLY →TYRA vs JNJ →TYRA vs ABBV →Stock screener →